Learning from failure: congestive heart failure in the postgenomic age

被引：36
|
作者：
Benjamin, IJ
Schneider, MD
机构：
[1] Univ Utah, Ctr Hlth Sci, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84132 USA
[2] Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA
[4] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2005年 / 115卷 / 03期
关键词：
D O I：
10.1172/JCI200524477
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The prognosis of heart failure is worse than that of most cancers, but new therapeutic interventions using stem and other cell-based therapies are succeeding in the fight against it, and old drugs, with new twists, are making a comeback. Genetically engineered animal models are driving insights into the molecular mechanisms that cause hearts to fail, accelerating drug discoveries, and inspiring cell-based therapeutic interventions for both acquired and inheritable cardiac diseases.
引用
收藏
页码：495 / 499
页数：5
相关论文
共 50 条
12345